Amniotic fluid in near-term pregnancies contains increasing amounts of free phospholipids and thromboplastins liberated from degenerating, desquamated fetal cells. Mature amniotic fluid is, therefore, likely to accelerate the clotting process. The accelerated clotting time (ACT) was obtained by adding 1.5 ml. of the patient's blood to 1.0 ml. of amniotic fluid in a plastic test tube at 37° C. Sixty-five third-trimester amniotic fluid samples from 28 patients demonstrated increasing “thromboplastic” or clot-accelerating activity with progressing pregnancy. ACT's from 277 amniotic fluid samples were estimated and correlated at the time of amniocentesis with gestation calculated retrospectively from pediatric assessment at birth. This was done in parallel with lecithin/sphingomyelin (L/S) ratio estimations and both were correlated with gestation. The range of ACT's obtained was 30 to 230 seconds. An ACT of less than 110 seconds usually indicated fetal maturity. The transitional zone was 95 to 120 seconds. Of the 277 estimations of ACT, L/S ratio, and gestation there was variance of assessment of maturity between ACT and L/S ratio in 33. L/S ratio gave only 11 (4 per cent) false results, 10 being false negative. ACT gave 22 (7.9 per cent) false results, 21 being false negative. Sixteen of the 22 errors were “transitional.” There were two cases of respiratory distress syndrome in the series, one predicted only by the L/S ratio, the other only by the ACT. Estimation of thromboplastic activity of amniotic fluid with ACT is a quick, simple, reliable method of estimating fetal maturity. Its rapidity and simplicity make it a rival of the shake and Nile blue sulfate tests, the result being available within five minutes of the amniocentesis. No test of fetal maturity is foolproof, and as multiple amniotic fluid estimations are proving more accurate than single estimations, the speed and simplicity of ACT make it an alternative method of amniotic fluid analysis.
Read full abstract